97 related articles for article (PubMed ID: 15754331)
1. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.
Geier MS; Tenikoff D; Yazbeck R; McCaughan GW; Abbott CA; Howarth GS
J Cell Physiol; 2005 Aug; 204(2):687-92. PubMed ID: 15754331
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
[TBL] [Abstract][Full Text] [Related]
3. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
4. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
Cooper HS; Murthy SN; Shah RS; Sedergran DJ
Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599
[TBL] [Abstract][Full Text] [Related]
6. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
7. The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
Ban H; Bamba S; Imaeda H; Inatomi O; Kobori A; Sasaki M; Tsujikawa T; Andoh A; Fujiyama Y
Oncol Rep; 2011 Jun; 25(6):1699-703. PubMed ID: 21431278
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
[TBL] [Abstract][Full Text] [Related]
10. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R
Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis.
L'Heureux MC; Brubaker PL
J Pharmacol Exp Ther; 2003 Jul; 306(1):347-54. PubMed ID: 12815012
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
Fukata M; Michelsen KS; Eri R; Thomas LS; Hu B; Lukasek K; Nast CC; Lechago J; Xu R; Naiki Y; Soliman A; Arditi M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1055-65. PubMed ID: 15826931
[TBL] [Abstract][Full Text] [Related]
13. Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis.
Albert EJ; Marshall JS
J Leukoc Biol; 2008 Apr; 83(4):833-42. PubMed ID: 18223102
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental colitis by intestinal mononuclear phagocytes.
Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
[TBL] [Abstract][Full Text] [Related]
15. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.
Deguchi Y; Andoh A; Inatomi O; Araki Y; Hata K; Tsujikawa T; Kitoh K; Fujiyama Y
Int J Mol Med; 2005 Oct; 16(4):605-8. PubMed ID: 16142393
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced colitis.
Renes IB; Boshuizen JA; Van Nispen DJ; Bulsing NP; Büller HA; Dekker J; Einerhand AW
Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G382-9. PubMed ID: 11804861
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
[TBL] [Abstract][Full Text] [Related]
20. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
